Evidence map›Paper›PMID 22425411›Full record

Trial reportDrug and alcohol dependence2012

A stage I pilot study of acceptance and commitment therapy for methadone detoxification.

Angela L Stotts, Charles Green, Akihiko Masuda, John Grabowski, Kelly Wilson, Thomas F Northrup, F Gerard Moeller, Joy M Schmitz

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05039554 (Randomized Trial of Acceptance and Commitment Therapy), which is not on this map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
5.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05039554 naactive not recruitingnot on this mapstarted 2023, after this paper: background citation

Randomized Trial of Acceptance and Commitment Therapy (ACT) and a Care Management App in Primary Care-based Buprenorphine Treatment

TypeinterventionalSponsorAlbert Einstein College of MedicineRan2023 to 2027Enrolled125ConditionsOpioid-use Disorder, Chronic PainArmsAcceptance and commitment therapy, Valera Smartphone Application, Treatment as Usual
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Methadone at tapered doses for the management of opioid withdrawal.The Cochrane database of systematic reviews · 2013
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Angela L StottsUniversity of Texas Medical School at Houston, 77030, USA. Angela.L.Stotts@uth.tmc.edu
Charles Green
Akihiko Masuda
John Grabowski
Kelly Wilson
Thomas F Northrup
F Gerard Moeller
Joy M Schmitz
Georgia State University · USUniversity of Minnesota System · USUniversity of Mississippi · US

Funding

Translational MR Imaging in Cocaine Pharmacotherapy DevelopmentP50DA009262 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MOELLER, FREDERICK GERARD · 1994 to 2014
$26.9M
Acceptance Therapy During Methadone DetoxificationR01DA019436 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI STOTTS, ANGELA L · 2005 to 2007
$976k
NIDA NIH HHS DA019436NIDA NIH HHS P50 DA009262NIDA NIH HHS P50DA009262NIDA NIH HHS R01 DA019436
6 · The paper itself

Abstract

backgroundWhile agonist replacement therapies are effective for managing opioid dependence, community treatment programs are increasingly choosing detoxification. Unfortunately, success rates for opioid detoxification are very low, in part, due to physical and psychological symptoms associated with opioid withdrawal. Few behavior therapies specifically address the distressing experiences specific to opioid withdrawal. A novel behavioral treatment, acceptance and commitment therapy (ACT), works from the premise that the avoidance of unpleasant private experiences (thoughts, feelings, bodily sensations) is ubiquitous yet may be pathogenic, resulting in treatment drop-out and further drug use.

methodsThis Stage I pilot study developed and tested an ACT-based opioid detoxification behavioral therapy. Opioid dependent patients (N=56) who were attending a licensed methadone clinic were randomized to receive either 24 individual therapy sessions of ACT or drug counseling (DC) in the context of a 6-month methadone dose reduction program.

resultsWhile no difference was found on opioid use during treatment, 37% of participants in the ACT condition were successfully detoxified at the end of treatment compared to 19% of those who received DC. Fear of detoxification was also reduced across time in the ACT condition relative to DC.

conclusionThis first study of ACT to assist opioid detoxification indicates promise. Research is needed to refine specific treatment strategies for this population to further strengthen effects.

Indexed as

AdultCounselingDiagnostic and Statistical Manual of Mental DisordersFearFemaleHumansInactivation, MetabolicMaleMental DisordersMethadoneMiddle AgedNarcoticsOpiate Substitution TreatmentOpioid-Related DisordersPatient Acceptance of Health CarePatient DropoutsMethadoneNarcotics

Identifiers

PMID22425411
PMCPMC3386351
OpenAlexW2046312939

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.